Incremental cost of conducting population-based prevalence surveys for a neglected tropical disease: the example of trachoma in 8 national programs. by Chen, Chaoqun et al.
Chen, C; Cromwell, EA; King, JD; Mosher, A; Harding-Esch, EM;
Ngondi, JM; Emerson, PM (2011) Incremental cost of conducting
population-based prevalence surveys for a neglected tropical disease:
the example of trachoma in 8 national programs. PLoS neglected
tropical diseases, 5 (3). e979. ISSN 1935-2727
Downloaded from: http://researchonline.lshtm.ac.uk/904/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/
Incremental Cost of Conducting Population-Based
Prevalence Surveys for a Neglected Tropical Disease: The
Example of Trachoma in 8 National Programs
Chaoqun Chen1, Elizabeth A. Cromwell2, Jonathan D. King2, Aryc Mosher2, Emma M. Harding-Esch3,
Jeremiah M. Ngondi2,4, Paul M. Emerson2*
1Georgia Institute of Technology, Atlanta, Georgia, United States of America, 2 The Carter Center, Atlanta, Georgia, United States of America, 3 The London School of
Hygiene and Tropical Medicine, London, United Kingdom, 4Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge,
Cambridge, United Kingdom
Abstract
Background: Trachoma prevalence surveys provide the evidence base for district and community-wide implementation of
the SAFE strategy, and are used to evaluate the impact of trachoma control interventions. An economic analysis was
performed to estimate the cost of trachoma prevalence surveys conducted between 2006 and 2010 from 8 national
trachoma control programs in Africa.
Methodology and Findings: Data were collected retrospectively from reports for 165 districts surveyed for trachoma
prevalence using a cluster random sampling methodology in Ethiopia, Ghana, Mali, Niger, Nigeria, Sudan, Southern Sudan
and The Gambia. The median cost per district survey was $4,784 (inter-quartile range [IQR] = $3,508–$6,650) while the
median cost per cluster was $311 (IQR = $119–$393). Analysis by cost categories (personnel, transportation, supplies and
other) and cost activity (training, field work, supervision and data entry) revealed that the main cost drivers were personnel
and transportation during field work.
Conclusion: Population-based cluster random surveys are used to provide the evidence base to set objectives and
determine when elimination targets have been reached for several neglected tropical diseases, including trachoma. The cost
of conducting epidemiologically rigorous prevalence surveys should not be a barrier to program implementation or
evaluation.
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Introduction
Trachoma is an eye disease, caused by infection with ocular
Chlamydia trachomatis, which causes blindness. However, trachoma
can be treated and prevented through the SAFE strategy,
endorsed by the World Health Organization (WHO): Surgery
for trichiasis; Antibiotic therapy through mass distribution; Facial
cleanliness promotion through health education; and Environ-
mental improvement with sanitation. Trachoma is endemic in 57
countries worldwide, with the burden of disease concentrated in
sub-Saharan Africa and the Middle East[1]. The WHO estimates
that over 80 million people currently have active trachoma and
another 8 million suffer from trichiasis, with a potential produc-
tivity loss of $2.9 billion annually at the global scale[2]. The World
Health Assembly has set 2020 as the target date for the elimination
of blinding trachoma worldwide[3].
Where trachoma is suspected to be a public health problem, the
WHO recommends that the prevalence of the clinical signs of the
disease are estimated using a cluster random survey methodology
at the district level[4]. There are two other less common methods
used to assess the burden of trachoma disease: trachoma rapid
assessments (TRA); and acceptance sampling trachoma rapid
assessment (ASTRA)[5,6]. As demonstrated in the literature[7],
the population-based probability sampling (PBPS) method is the
most epidemiologically robust method available to generalize the
prevalence of clinical signs to the domain of interest.
In brief, the PBPS method employs a multi-stage cluster
random survey design to randomly select clusters, and households
within the clusters. Once households are selected, all members of
the household are examined for clinical signs of trachoma disease
using the WHO Simplified Grading System[8]. Survey team
members are trained to conduct trachoma grading and household
selection before participating in survey field work. Most survey
teams consist of pairs of trachoma examiners and recorders, with
one or two pairs needed to survey a cluster. Upon completion,
double entry of survey data and analysis are performed by
temporary staff or non-governmental organizations and Ministry
of Health personnel.
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Trachoma prevalence surveys provide an estimate of the burden of
disease at the level of interest, usually the district. These data serve as
the evidence base for determining how the SAFE strategy should be
employed. For example, where the prevalence of the clinical grade
TF (trachomatous inflammation, follicular) exceeds 10% in children
aged 1–9 years, the WHO recommends district-wide mass treatment
with antibiotics and facial cleanliness and environmental improve-
ments—the ‘‘AFE’’ of SAFE. Prevalence survey data are also used to
calculate annual intervention targets and ultimate intervention goals
(UIGs), such as the number of people who require trichiasis surgery.
These targets are used to plan annual activity budgets, forecast the
need for donated pharmaceuticals and other supplies, and monitor
progress towards the elimination of blinding trachoma.
Although survey implementation may vary by location, there
are currently no data on the cost of trachoma prevalence surveys
in the peer-reviewed literature. There are examples in the
literature where different survey methods were compared to
determine the most cost-effective method to estimate immuniza-
tion coverage[9,10]. While comparisons such as these can be used
to evaluate the cost-effectiveness of different survey methods, they
do not provide sufficient data to generalize the cost of conducting
these surveys at the regional or global level. In this paper, we
present an analysis of costs incurred in the implementation of
trachoma prevalence surveys across eight national trachoma
control programs. The findings from this analysis will enable
national trachoma program managers and international partners
to budget for trachoma prevalence mapping appropriately.
Methods
Ethics Statement
The analysis of prevalence survey cost data did not involve any
research on human subjects. The prevalence surveys reviewed in
this paper were conducted in accordance with the Declaration of
Helsinki and reviewed by the Emory University Institutional
Review Board or the London School of Hygiene and Tropical
Medicine (LSHTM) Ethical Committee and each country’s
respective Ministry of Health. External funding for the prevalence
surveys was as follows: LSHTM, The Gambia survey; Helen
Keller International, Sikasso Region of Mali; The International
Trachoma Initiative and The Carter Center, 18 districts in
Ghana; The Carter Center, all other surveys.
Data Collection
A systematic review of trachoma prevalence surveys conducted
in Ethiopia, Ghana, The Gambia, Mali, Niger, Nigeria, Sudan,
and Southern Sudan was performed February through May 2010.
This review of prevalence survey costs included surveys that
employed a PBPS methodology to estimate trachoma prevalence
at the district level, or the administrative unit equivalent to a
district (administrative unit with population of approximately 100–
250 thousand people: woreda in Ethiopia, region in The Gambia,
local government area in Nigeria, locality in Sudan, and county in
Southern Sudan). Included surveys were implemented from 2006–
2010, and funded or co-funded by The Carter Center, LSHTM
(The Gambia), The International Trachoma Initiative (Ghana), or
Helen Keller International (Sikasso Region, Mali). All surveys
were ‘cluster random surveys’ that used a two stage sampling
process to select clusters (communities, villages, or enumeration
areas) representative of the domain in the first stage and
households within the cluster in the second. The numbers of
clusters and households in the surveys was not constant between
districts.
A data collection tool was used to collect the actual costs
incurred in local currency during survey activities from accounting
records in the programs. The tool collected data for four cost
activities: training, field work, supervision and data entry. Training
included costs such as per diem of trainees and trainers, meeting
facility and supplies, transportation to the practical exercise and
any required overnight accommodation. Field work costs included
per diems for survey personnel (trachoma grader and recorder),
transportation of survey field team, accommodation and supplies
such as tetracycline eye ointment and magnifying loupes.
Supervision included any per diem, transport and accommodation
paid to Ministry of Health or NGO personnel retained for
supervision of field work activities. Data entry costs included per
diem of data entry clerks, cost of computer rental and information
technology support (if required) and supplies. For each cost
activity, data were collected on the number of people paid, the
daily rate and the number of days paid. Transportation costs
included any vehicle rental, fuel expense and driver per diem.
The data collected in this study captured the incremental cost of
conducting prevalence surveys in the context of an existing
national trachoma control program. Ministry of Health and NGO
salaries and other associated costs were not included in the
analysis. Integrated prevalence surveys (more than one disease
measured) were excluded from this analysis. ‘‘Headquarters’’
expenses were not included in the primary analysis of prevalence
survey costs. Although beneficial, consultant or other outside
technical assistance is not required for a national program to
conduct trachoma prevalence surveys. Furthermore, the cost of
outside technical assistance is dependent on travel expense policies
which are unique to each partner. The cost of Carter Center
headquarter support for specific survey activities are reported in
this review, but were not included in the district-level cost data, as
these costs are organization-specific and cannot be generalized.
Once completed, the cost data forms were verified against the
financial reports from the Carter Center, Helen Keller Interna-
tional, LSHTM or the Ministries of Health. In Ghana, Ethiopia
and Northern Sudan, exact data on distance traveled were not
available; the data reported for these programs’ distance traveled
are estimates from the national programs.
Data Analysis
Data were converted to US dollars using the mean of the
weighted average exchange rate from the World Bank (http://
data/worldbank.org/indicator/PA.NUS.FCRF) for the years
Author Summary
The costs of conducting population-based prevalence
surveys for neglected tropical diseases such as trachoma
are often cited as a reason that program managers do not
conduct baseline or impact assessments when guidelines
suggest they are warranted. The authors conducted a
review of actual costs incurred during the implementation
of 165 district level surveys in 8 national trachoma control
programs to identify the median and mean costs per
district and per cluster. In addition, the costs of the
principal activities that are the most expensive were
measured. The data show that field work is the most
expensive activity for a prevalence survey, with personnel
(per diems, allowances and accommodation) and transport
costs driving the total cost of the survey. These findings
can be used by program managers to budget for
population-based prevalence surveys that are recom-
mended for baseline and evaluation surveys, and periodic
uptake surveys for neglected tropical diseases such as
trachoma.
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2007–2009. Since most district-level prevalence surveys were
conducted in groups (i.e. all districts in a region surveyed at the
same time), costs were not reported for each individual district.
Rather, each ‘‘grouping’’ of surveys that were financed at the same
time was analyzed as the same observation. For example, in the
Kayes Region of Mali, all 7 districts were surveyed using the same
survey personnel within the same period of time. Funds were
provided to the Ministry of Health to conduct the survey work for
the entire region, which resulted in efficiencies gained by
conducting one initial training and reducing the amount of
transport required. Where data were reported in this fashion, the
districts are treated as the same observation in the analysis.
Based on these observations, the analysis generates the overall
costs, the average survey costs per district and average costs per
cluster for each observation. Data were first entered into Excel and
then analyzed using STATA to generate descriptive statistics for
each cost activity. Subsequently, a cost composition analysis was
performed. The data were classified into activities as defined in the
data collection tool to calculate the proportion of the total cost for
each cost activity. Within each of the four activities (training, field
work, supervision and data entry), four main cost categories were
identified: personnel, transportation, supplies and other. The costs
for each category were compared against the total cost for each
activity to identify the main cost drivers of survey expenses.
Normally distributed data are presented as the mean and
standard deviation (SD). Not-normally distributed data is present-
ed by the median and inter-quartile range (IQR).
Results
Survey Costs
A total of 29 observations were collected from eight national
trachoma control programs. The cost per district by observation is
presented in Table 1. Overall, a total of 165 district-level surveys
were included (Figure 1), representing a total of 3,203 clusters
surveyed. The average costs per district were skewed to the right
by an outlier (Ayod in Southern Sudan, $25,409) so are described
by the median, $4,784 and IQR, $3,508–$6,650. The median cost
per cluster was $311 (IQR= $119–$393) whilst the median cost
per person screened was $3.50 (IQR=1.94–4.16). (The mean cost
per district, cluster and person was $5,849 (SD= $4,635), $324
(SD= $236), and $3.39 (SD= $2.02) respectively). The least
expensive survey per district was in Ethiopia, approximately
$1,511 per district. The number of districts, clusters and persons
sampled per observation is presented in Table 1.
Composition of Survey Costs
When the costs for each survey activity were compared against
the total cost (Table 2), the data showed that field work comprised
on average 69.9% of the total cost of a survey. Among the
observations, the proportion of total costs spent on field work
ranged from 44.9% to 90.5%. Training costs ranged from 1.0% to
29.6% of total costs, supervision expenses were between 0.0% and
20.9% of the total, and data entry costs ranged from 0.0% to
25.0% across all observations. Within each survey activity,
personnel costs were the most expensive, with personnel costs in
field work accounting for 40.4% of the total survey costs reported
by the national programs, followed by transportation during field
work at 22.4%.
Training and data entry activity costs were reported by
observation as the cost for each activity. These costs were not
always directly related to the number of districts surveyed as some
programs did not incur cash costs for these activities. The mean
cost of training was $1,342 (SD $659) while the median was
$1,791.50 (IQR= $588–$1,816). The mean cost of data entry was
$2,548 (SD $3,493) and the median was $1,028 (IQR= $415–
$4,431).
Costs of ‘Headquarters’ Participation in Surveys
Although the cost of outside technical assistance was not
factored into the district or cluster level cost analysis, there were 9
observations that were surveyed with at least one representative
from The Carter Center Headquarters (Atlanta, Georgia, USA)
present, covering a total of 58 districts. The average cost for
airfare, hotel, meals and incidentals per person-trip was $1,779
(n= 13, SD= $2,027) from 2006–2010.
Discussion
It is possible that trachoma control programs do not implement
prevalence surveys due to a perception that the costs will be
beyond the capacity of the program. However, the results of this
analysis show that such surveys are not cost-prohibitive. The range
of costs per district varied from $1,151–$25,409, in large part due
to differences in accessibility and the number of clusters sampled in
each survey. Of the 29 observations, only three surveys reported a
cost per cluster exceeding $500: Ayod in Southern Sudan, Kidal in
Mali and the Northern Region in Sudan. These surveys were
characterized by both high transport and personnel costs. In Ayod
County of Southern Sudan, where the average cost per cluster was
$1,270 and average cost per person screened was $10.88, vast
distances of water-logged and unforgiving terrain made vehicle
transport impossible, requiring a chartered airplane to transport
staff to airstrips from where they traveled to the clusters on foot
over a period of days. These exceptional circumstances therefore
required additional staff, working for a longer period of time, and
transport by chartered aircraft. In Kidal Region (a desert region of
Mali), the second most expensive survey per cluster ($739 per
cluster, $6.83 per person screened), the sparse population (80,000)
and low population density (less than one person per square
kilometer) resulted in the national program treating the region as
the domain, with the consequence that the distances between
clusters was hundreds of kilometers. To conduct this survey, the
program rented vehicles instead of using Ministry of Health and
NGO transport due to security concerns in the area. The
Northern Region of Sudan ($552 per cluster, $3.29 per person
screened) is also on the edge of the Sahara with similar demands
on transport and time. Least expensive, at under $100 per cluster,
were the surveys conducted in the Amhara region of Ethiopia ($84
per cluster, $1.31 per person screened) and Plateau and Nasarawa
States of Nigeria ($92 per cluster, $1.11 per person screened)
where per diem rates were low and the population is relatively
dense, reducing both the travel costs and time spent travelling
between clusters. In total, 7 observations cost less than $125 per
cluster and these also had the lowest cost per person screened
($0.91–$1.31). In these surveys, the relative proximity of clusters
and low per diem rates contributed to lower costs in comparison to
the more expensive surveys.
Among the cost categories reported, the per diem of field staff and
supervisors and the cost of transportation accounted for 73% of
the total survey costs. In settings where distances between
communities are great, trachoma control programs may consider
reducing the number of clusters surveyed and increase the number
of people screened per cluster to reduce costs but maintain an
adequate sample size. However, the risks to accuracy and
precision around the prevalence estimate should be considered.
Cost savings on transport and accommodation costs can be
achieved by planning the route of vehicles between clusters
Cost of Trachoma Surveys in 8 National Programs
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carefully. A route for two teams can often be planned in which the
teams share one vehicle, work in the first and second clusters
simultaneously (with the vehicle shuttling between as necessary)
and then travel together to the next cluster where they camp for
the night and sensitize the village population of the survey to be
conducted the following day. Such transport sharing and camping
has been both effective and enjoyable in most of the countries in
this analysis. Per diem and allowance costs vary by national
program, level of trained personnel recruited to serve as survey
team members and local supervision requirements. Per diem costs in
the surveys studied ranged from $6.21 per day for graders (junior
health staff) to $250 a day for senior supervisors (an ophthalmology
professor and National Coordinator). When designing surveys, due
consideration should be given to assign roles and responsibilities
consistent with the qualification and per diem given. Junior health
staff who are comfortable with the climate, social circumstances
and geography of the area to be surveyed make ideal field staff,
and serve to lower per diem costs. It is appropriate for a National
Coordinator or ophthalmology professor to spend a day or two
testing the ability of the trained examiners before the survey starts,
but costs can be reduced if that person does not spend many days
in the field.
The review of data entry costs also presents new findings for
Ministries of Health. Although data entry was not an expense for
Table 1. Summary of total costs, by observation.
National
program Observation
Number
of districts
Number
of clusters
Number of
households
per cluster
Number of
people
examined
Total
costs ($)
Cost per
district ($)
Cost per
cluster ($)
Cost per
person
screened
($) Reference
Ghana Northern &
Upper West
18 720 30 74,225 72,249 4,014 100 0.97 Yayemain
2009
Mali Kidal 1 20 24 2,165 14,777 14,777 739 6.83 Bamani 2010
Kayes 7 140 24 13,576 13,593 1,942 97 1.00 Bamani 2010
Koulikoro 9 180 24 19,342 17,505 1,945 97 0.91 Bamani 2010
Sikasso 8 160 24 18,795 19,046 2,381 119 1.01 PNLCC
Segou 8 160 24 16,471 18,553 2,319 116 1.13 PNLCC
Nigeria Plateau &
Nasarawa
13 260 16 21,606 24,036 1,849 92 1.11 King 2010
Southern
Sudan
Jonglei
(Ayod County)
1 20 20 2,335 25,409 25,409 1,270 10.88 King 2008
Northern
Sudan
Kassala 10 132 30 10,576 35,308 3,531 267 3.34 FMOH GOS
Blue Nile 4 45 20 5,166 18,799 4,700 418 3.64 FMOH GOS
Gazeira 7 105 20 10,466 42,049 6,007 400 4.02 FMOH GOS
White Nile 8 120 20 10,570 39,168 4,896 326 3.71 FMOH GOS
Gadarif 10 150 20 13,682 47,839 4,784 319 3.50 FMOH GOS
Sinnar 7 105 20 9,095 34,961 4,994 333 3.84 FMOH GOS
River Nile 6 90 20 7,528 20,632 3,439 229 2.74 FMOH GOS
Red Sea 10 150 20 9,918 40,680 4,068 271 4.10 FMOH GOS
Northern 5 66 20 11,076 36,454 7,291 552 3.29 FMOH GOS
North
Kordofan
9 135 20 10,360 37,494 4,166 278 3.62 FMOH GOS
South
Kordofan
9 135 20 10,755 41,960 4,662 311 3.90 FMOH GOS
Niger Magaria 1 20 24 1,789 7,884 7,884 394 4.41 PNLCC Niger
Matameye 1 20 24 1,712 7,835 7,835 392 4.58 PNLCC Niger
Nguigmi 1 20 24 1,659 7,866 7,866 393 4.74 PNLCC Niger
Maine Soroa 1 20 24 1,867 7,866 7,866 393 4.21 PNLCC Niger
Maradi
Commune
1 20 24 2,393 6,132 6,132 307 2.56 PNLCC Niger
Tessaoua 1 20 24 1,806 6,132 6,132 307 3.40 PNLCC Niger
Gaya 1 20 24 2,036 6,650 6,650 333 3.27 PNLCC Niger
Loga 1 20 24 1,801 6,650 6,650 333 3.69 PNLCC Niger
Ethiopia Amhara 5 90 10 5,762 7,556 1,511 84 1.31 Ngondi 2008
The Gambia Lower River &
North Bank
2 60 25 2,990 7,815 3,908 130 2.61 Harding-Esch
2009
Total 165 3,203 301,552 672,897
doi:10.1371/journal.pntd.0000979.t001
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all surveys reported, data entry accounted for an average of 11%
of total survey expenses. In this sample, the incremental cost of
data entry ranges from 0% in surveys where existing program staff
conducted data entry on existing computers incurring no
additional cash cost to 25% of the total cost of the survey where
external contractors were hired to complete the work. Survey
planners should consider the cost of data entry in their own
country context to ensure that costs for double entry, analysis and
preparation of printed reports are included in budgets.
By design, we did not capture the cost of each Ministry of
Health and NGO employee who contributed time to conduct
survey work, the incremental cost effectiveness ratio is likely to be
underestimated since these costs were not taken into account. This
could be included in the analysis as an opportunity cost. However,
since the implementation of prevalence surveys is recommended as
the standard monitoring and evaluation framework for trachoma
control programs by the WHO, these surveys were within the
mandate of the Ministry of Health personnel who were engaged in
field work and supervision. Salary costs were excluded as they
were considered part of the functional trachoma control program
and we sought to establish the incremental cost of conducting
surveys in the presence of a program. We also did not include the
cost of technical assistance (including travel) for ‘headquarters’
staff. Although the average cost of a person-trip from The Carter
Figure 1. Map of district-level trachoma prevalence surveys included in the cost analysis.
doi:10.1371/journal.pntd.0000979.g001
Table 2. Average proportion of total survey costs attributed to cost categories and activities.
Activities
Training Field work Supervision Data entry Total
Category
Personnel 1.9% 40.4% 11.3% 10.9% 64.6%
Transportation 1.6% 22.4% 1.7% 0.0% 25.7%
Supplies 0.9% 5.3% 0.0% 0.0% 6.3%
Others 1.4% 1.7% 0.3% 0.0% 3.3%
Total 5.9% 69.9% 13.2% 10.9% 100.0%
doi:10.1371/journal.pntd.0000979.t002
Cost of Trachoma Surveys in 8 National Programs
www.plosntds.org 5 March 2011 | Volume 5 | Issue 3 | e979
Center for technical assistance was $1,779 (SD= $2,027), we
considered this to be a non-essential cost for a program, subject to
considerable variation between supporting NGOs who have
different travel policies, and likely to come from a different
operating budget which would not have an incremental effect on
the cost of a national program.
The selection of a sample representative of the underlying
population presents an opportunity to collect data on multiple
conditions and this has been done for trachoma and malaria[11]
and trachoma and urinary schistosomiasis[12]. Such integrated
surveys were not included in this analysis since they were
considered special cases and not what is typically done. However,
the costs of adding indicators for additional diseases or conditions
are the additional personnel, equipment and consumables
required for that survey, with the other cost items such as
transport and per diem of the drivers and assistants covered by the
‘parent’ survey.
Although the data presented show costs from a variety of
settings, there are a few limitations. The data in this analysis were
reported retrospectively and therefore, it is possible that some costs
may not have been captured. For some surveys (Ghana, Ethiopia
and Northern Sudan) log book entries for distance travelled were
not available and we relied on the local knowledge of the national
program to calculate distance travelled. Each of these surveys was
conducted in the presence of a functioning trachoma control
program; there was no need to purchase new vehicles or make
other large capital expenses. Survey work performed in the
absence of this infrastructure would be more expensive. New
country programs may find it necessary to rent vehicles and seek
technical assistance for training survey staff, the costs of which
would need to be considered in addition to the incremental costs of
conducting a survey presented here.
There are variations in the number of clusters surveyed among
the different observations, based on the population of each survey
domain, which may affect the comparability of the survey costs
among different countries. However, the authors expected
variation among national programs due to differences such as per
diem rates, the level of qualified health professional involved in field
work, and the capacity to complete data entry. The variation seen
in these data illustrate the context-specific nature of planning
survey activities. However, these limitations should not discourage
program managers from using the data presented in this paper as
benchmarks for determining funding needs.
Twenty-six out of the 29 observations were conducted with
external funding exclusively from The Carter Center, which may
imply the cost estimates are limited to those surveys supported by
this NGO. However, there are similarities between the cost per
cluster from The Gambia, which was fully funded by LSHTM,
districts in Mali supported by Helen Keller International, and
districts in Ghana co-sponsored by the International Trachoma
Initiative and The Carter Center. This suggests that our findings
are not unique to the operating principles of one NGO.
Since transport and per diem were identified as major cost
drivers, it is possible to predict total survey costs for areas requiring
surveys. It is also possible to use these data to project the cost of
other survey methodologies by applying the average cost per
cluster to the number of clusters required. Despite the potential
limitations of this study, these data present the only summary of
actual costs incurred during trachoma prevalence surveys in the
peer-reviewed literature. For the goal of elimination of blinding
trachoma worldwide by 2020 to be met, national programs will
need to budget for impact evaluation at the district level. The cost
of epidemiologically rigorous surveys should not been seen as a
barrier to their implementation. With adequate baseline and
impact evaluation data, national programs can maximize their
limited programmatic resources. These data should inspire
national trachoma program managers and ministry of health staff
involved in other public health supervisory roles to consider
implementation approaches that ensure surveys are designed in a
cost-effective and efficient manner. These cost data will enable the
international trachoma control community to create global
estimates on the cost to complete trachoma prevalence mapping
and estimate the financial needs to support impact assessments to
measure progress towards the elimination of blinding trachoma.
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